Head-to-head · Cost-Efficiency Index
CaliberRx vs LillyDirect Foundayo
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CaliberRx
Shoppers who want simple flat-rate pricing and a clear, published list of excluded states.
Visit CaliberRxLillyDirect Foundayo
Patients who want an FDA-approved, manufacturer-direct oral GLP-1 rather than a compounded injectable.
Visit LillyDirect FoundayoThe verdict
CaliberRx and LillyDirect Foundayo tie on the Cost-Efficiency Index at 63/100, so neither wins outright on the numbers. For most shoppers we'd start with CaliberRx (ranked #189, a hair above #196) — Shoppers who want simple flat-rate pricing and a clear, published list of excluded states. But LillyDirect Foundayo is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs CaliberRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CaliberRx | LillyDirect Foundayo |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 63/100 |
| Semaglutide / mo | $199/mo (all doses, compounded) | Not disclosed |
| Tirzepatide / mo | $199/mo (all doses, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,388 | — |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #189 | #196 |
CaliberRx
63/100Where the value is
- Flat, identical $199/month pricing for both semaglutide and tirzepatide -- no confusing dose tiers to compare
- No prepay or first-month-only trap detected on the pages checked
- LegitScript certification verifiably linked
The tradeoffs
- No individual medical director named
- No compounding pharmacy named
LillyDirect Foundayo
63/100Where the value is
- First-party Eli Lilly program -- highest possible manufacturer authenticity
- FDA-approved branded drug (orforglipron), not an unapproved compounded formulation
- Published self-pay starting price ($149) via savings card
The tradeoffs
- Not semaglutide or tirzepatide -- a different molecule (orforglipron), so not directly comparable on this list
- The $149 price is tied to a specific Savings Card program with its own terms, not an unconditional list price
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.